Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Gentronix, Part of Scantox Group logo — Predictive Toxicology, Expertly Delivered

Gentronix, Part of Scantox Group

Predictive Toxicology, Expertly Delivered

Founded 1999 United Kingdom Alderley Edge, United Kingdom 64 employees Series Unknown Total: $3.58M Biotechnology, Wellness Beauty

General Information

Company Name Gentronix, Part of Scantox Group
Founded Year 1999
Location United Kingdom Alderley Edge, United Kingdom +1
Employees 64
Industries Biotechnology, Wellness Beauty
Funding Stage Series Unknown
Social

Get notified when Gentronix, Part of Scantox Group moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Gentronix, Part of Scantox Group

Gentronix Limited is a biotechnology startup based in the United Kingdom, specializing in delivering predictive toxicology products and services to global chemical sectors. With a focus on genetic toxicology and skin sensitization, the company works with organizations from early screening through to regulatory safety assessment, providing innovative solutions for identifying genotoxic hazards and assessing chemical safety. Established in 1999, Gentronix has been a key player in the predictive toxicology space for over 20 years, assisting clients in optimizing their development programs. The company offers a comprehensive portfolio of screening and regulatory genotoxicity products and services, as well as the assessment of skin sensitization potential. Gentronix recently received a £700.00K Venture Round investment on 15 November 2021, with Mercia Fund Managers participating as the investor. This investment highlights the recognition and confidence in the company's expertise in the field of predictive toxicology. With its established track record and focus on innovation, Gentronix is well-positioned to further solidify its standing as a leader in the predictive toxicology industry.

Taxonomy: Predictive Toxicology, Genotoxicity Assessment, Chemical Safety, CRO, Chemical Screening, Genetic Toxicology, Skin Sensitisation, Development Programmes, Chemical Industries, Innovative Solutions, Global Reach, Early Screening, Safety Assessment

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 15 Nov 2021
Venture Round •••••• 1 •••• •••• 20 Jan 2020
Venture Round •••••• 1
Investor
05 Mar 2007
Grant •••••• - 01 Jul 2006
Venture Round •••••• 2
Investor
•••• •••• 		01 May 2005

View All 6 Funding Rounds

Gentronix, Part of Scantox Group Alternatives & Competitors

Gentronix, Part of Scantox Group vs
Gradient
Gradient United States

SCIENCE AND STRATEGIES FOR HEALTH AND THE ENVIRONMENT

199 employees
Biotechnology, Health Care
Compare Gentronix, Part of Scantox Group vs Gradient
Gentronix, Part of Scantox Group vs
Toxys
Toxys The Netherlands

Genetic, developmental, and investigative toxicology with New Approach Methodologies (NAMs)

Series Unknown
41 employees
Biotechnology, Health Care
Compare Gentronix, Part of Scantox Group vs Toxys
Gentronix, Part of Scantox Group vs
Trinity Consultants - SafeBridge
Trinity Consultants - SafeBridge

Scientific Solutions to Safety Problems

54 employees
Health Care
Also compare with: Gentronix, Part of Scantox Group vs CFCS-Consult GmbH CFCS-Consult GmbH

FAQ About Gentronix, Part of Scantox Group

Predictive Toxicology, Expertly Delivered
Gentronix, Part of Scantox Group was founded in 1999.
Gentronix, Part of Scantox Group is headquartered in Alderley Edge, United Kingdom.
Gentronix, Part of Scantox Group operates in the following industries: Biotechnology, Wellness Beauty.
Gentronix, Part of Scantox Group has approximately 64 employees.
Gentronix, Part of Scantox Group has completed 6 funding rounds, raising a total of $3.58M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Gentronix, Part of Scantox Group include Gradient, Toxys, Trinity Consultants - SafeBridge, CFCS-Consult GmbH, Intertox, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gentronix, Part of Scantox Group and Gradient are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Gentronix, Part of Scantox Group and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes